The Potentiating Effect of GLP-1 on Glucose-induced Glucagon Suppression in Healthy Individuals and in Patients with Type 1 and 2 Diabetes

被引：0
|
作者：
Bagger, Jonatan I.
Lund, Asger
Grondahl, Magnus
Holst, Jens J.
Vilsboll, Tina
Knop, Filip K.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1890-P
引用
收藏
页码：A487 / A487
页数：1
相关论文
共 50 条
  • [21] Effect of Intensive Lifestyle Intervention on Glucagon like Peptide-1 (GLP-1) Levels in Patients with New Onset Type 2 Diabetes
    Bowes, Anita
    Begley, Joe
    Hart, Tanya
    Painter, Hannah
    Kerr, David
    DIABETES, 2009, 58 : A98 - A99
  • [22] Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
    Brunner, Martina
    Moser, Othmar
    Raml, Reingard
    Haberlander, Maximilian
    Boulgaropoulos, Beate
    Obermayer-Pietsch, Barbara
    Svehlikova, Eva
    Pieber, Thomas R.
    Sourij, Harald
    BIOMOLECULES, 2022, 12 (03)
  • [23] Effects of Sitagliptin and Metformin Treatment on GLP-1 Responses to Oral Glucose and on the Incretin Effect in Patients With Type 2 Diabetes
    Vardarli, Irfan
    Arndt, Elisabeth
    Deacon, Carolyn F.
    Holst, Jens J.
    Kothe, Lars D.
    Nauck, Michael A.
    DIABETES, 2012, 61 : A17 - A17
  • [24] Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
    Salehi, Marzieh
    Aulinger, Benedict
    Prigeon, Ronald L.
    D'Alessio, David A.
    DIABETES, 2010, 59 (06) : 1330 - 1337
  • [25] An investigation into the efficacy of glucagon-like peptide 1 (GLP-1) analogues in obese patients with Type 1 diabetes
    Shah, M. K.
    Danjuma, M.
    Saeed, T.
    Khan, E. G.
    DIABETIC MEDICINE, 2014, 31 : 178 - 178
  • [26] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [27] GLP-1 agonists in type 1 diabetes
    Pettus, Jeremy
    Hirsch, Irl
    Edelman, Steven
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 317 - 323
  • [28] GLP-1 Agonists: Improving the Future of Patients With Type 2 Diabetes
    Shubrook, Jay H.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (02): : ESII - ES1
  • [29] Head to head comparison of glucagon-like peptide 1 (GLP-1) agonists and insulin in patients with Type 2 diabetes
    Siddiqi, Al
    Nambi, S.
    DIABETIC MEDICINE, 2013, 30 : 163 - 163
  • [30] Glucagon-like peptide-1 (GLP-1) levels in obese patients with and without type 2 diabetes.
    Mannucci, E
    Ognibene, A
    Cremasco, F
    Bardini, G
    Mencucci, A
    Ciani, S
    Messeri, G
    Rotella, CM
    DIABETOLOGIA, 2000, 43 : A146 - A146
12345